You are here: Home » PTI Stories » National » News
Business Standard

Sundyota Numandis launches anti-diarrhea probiotic

Press Trust of India  |  Ahmedabad 

City-based healthcare solutions firm today announced the pan-launch of its anti-probiotic product rhamnosus GG, considered as the world's most scientifically studied probiotic for gastro-intestinal health.

To make this product available in India, Sundyota Numandis has entered into a strategic partnership with Italian firm Probiotical, a global leader in bacterial probiotic therapies, announced Dinesh Arora, managing director and chief executive officer of Group, at a press meet here today.

"As per the agreement, procures coated oro-soluble L.rhamnosus GG formula from the Italian firm and undertakes its for the Indian market under the brand name SuperFlora GG. It will be sold in a sachet form," said Arora.

are live and yeasts which are considered good for health, especially the Unlike anti-biotic drugs, does not leave any harmful side effects in the body, he added.

Apart from selling their product, the company has also entered into a strategic alliance with for marketing the same product under the brand name Unobiotics.

"Such agreement is aimed at extending benefits to a larger consumer base," said Arora.

In his opinion, the Indian probiotic market is valued at about Rs 1,000 crore and growing at a rate of 15 per cent.

"While are very popular in western countries, it is now becoming popular in We estimate that the market would touch the Rs 10,000-crore mark in the next 10 years" he said.

While the current product is being manufactured by a third party at its facility in Himachal Pradesh, Arora said Sundyota Numandis plans to start its own facility at Changodar industrial area here in near future with an investment of Rs 51 crore.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, April 11 2018. 16:40 IST